ArticleBMC cancer2026
Non-invasive diagnostic evaluation of urinary exosomal let-7c cluster expression in bladder cancer using machine learning approaches.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundBladder cancer (BCa) diagnosis typically relies on invasive cystoscopy, which is effective but costly and uncomfortable. Urinary microRNAs (miRNAs), especially exosomal ones, are promising non-invasive biomarkers due to their stability in biological fluids and disease specificity. The let-7c cluster, owing to its tumor-suppressive function and frequent dysregulation in BCa, has emerged as a promising candidate for diagnostic evaluation. This study assessed the diagnostic potential of the urinary exosomal let-7c cluster through Machine Learning (ML)-integrated miRNA profiling, offering early proof-of-concept for its role in BCa classification.
methodsUrine samples were collected from 66 participants, including 50 BCa patients and 16 healthy controls (HC). Exosomal miRNAs were isolated and quantified using Quantitative Real-Time-Polymerase-Chain-Reaction (qRT-PCR). Statistical analysis and hypothesis tests were conducted to explore the nature and diagnostic relevance of individual biomarkers. A logistic regression classifier was applied to evaluate both the combined and differential diagnostic capabilities of the selected biomarkers. Accuracy, precision, recall and AU-ROC scores were used to assess model performance. Bioinformatics analysis was performed to identify pathways associated with the features prioritized by the ML models, ensuring their relevance to BCa.
resultsStatistically significant differentiation was observed between BCa patients and HC, with miR-99a-5p (p = 0.013, AU-ROC = 0.71) demonstrating preliminary diagnostic performance. In contrast, let-7c-5p (AU-ROC = 0.65, p > 0.1) and miR-125b-5p (p = 0.087, AU-ROC = 0.64) exhibited non-significant trends, showing weaker discrimination. The logistic regression ML model achieved 80.0% accuracy (AU-ROC = 0.86, recall = 90%) in distinguishing cancer from HC and 53.3% (AU-ROC = 0.63) for miRNA-only grade classification. With clinical variables added, accuracy increased to 73.3%, but the AU-ROC remained modest at 0.61, indicating limited discriminatory ability in high-grade versus low-grade. Across Ta-T2, miR-99a-5p showed clearer separation, whereas let-7c-5p and miR-125b-5p exhibited weak stage-related differences. Bioinformatics analysis confirmed the biological relevance of these miRNAs in BCa-related pathways, including PI3K-Akt, p53, NF-κB and RAS/MAPK signaling, with hub genes such as TP53, MYC, EGFR and CCND1 identified.
conclusionUrinary let-7c cluster miRNAs show preliminary diagnostic potential when evaluated using ML models and may serve as a non-invasive supportive tool to conventional diagnostic approaches. However, these results should be regarded as proof-of-concept evidence that has to be validated in larger, independent cohorts because of the small sample size, low subgroup power and class imbalance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.